Training program: "Pharmacist and osteoporosis" (2002-2003)

Partners
Cespharm, UTIP Association, GRIO, IOF, LEEM, seven pharmaceutical companies (The Alliance for Better Bone Health: Aventis and Procter & Gamble, HRA-Pharma, Lilly, MSD, Pierre Fabre and Roche).

Content
This training program has been designed to update pharmacists' knowledge and to involve them in prevention, early detection and pharmaceutical care of osteoporotic patients.

This training program received scientific approval from the professionnal committee in charge of evaluating the quality of continuing education programmes for french community pharmacists (HCFPC).

Duration
2 hours in the evening

Assessment
Twenty-six regional training sessions were attended by 2,840 pharmacists between November 2002 and November 2003. The evaluation data highlight the great satisfaction of the pharmacists and the important benefit of the program on their required knowledge.

Poster displayed at the 64^th FIP Congress New Orleans, USA, September 2004